UroGen Pharma (URGN) PT Raised to $40 at Oppenheimer
Tweet
Share
E-mailGet Alerts URGN Hot Sheet
Price: $41.35 +0.29%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell raised the price target on UroGen Pharma (NASDAQ: URGN) to $40.00 (from $34.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Slate Grocery REIT (SGR-U:CN) (SRRTF) PT Lowered to $8.75 at Scotiabank
- LTIMindtree Ltd (LTIM:IN) PT Lowered to INR3,620 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
